THE WHAT? Saudi Arabia’s Food and Drug Authority (SFDA) is introducing new packaging and labelling requirements for cosmetics presented in syringe, ampoule and vial formats, effective January 1, 2027.
THE DETAILS Under the new rules, cosmetics intended for external use will be prohibited from being sold in syringe-style packaging due to the risk of products being mistaken for injectable pharmaceuticals. Cosmetics in ampoules and vials can remain on the market but must carry clear warnings in Arabic and English stating that they are for external cosmetic use only and must not be injected. Labels must also warn consumers to avoid eye contact and take care when opening the products. Marketing materials will be prohibited from suggesting that cosmetics can be administered by injection or any device that penetrates the skin. Manufacturers and importers have until December 31, 2026 to withdraw affected products or bring their packaging and labelling into compliance.
THE WHY? The regulation creates an important compliance deadline for beauty manufacturers, brands and importers operating in Saudi Arabia, particularly those selling serums and other concentrated cosmetic treatments in pharmaceutical-inspired formats. Companies will need to review packaging, labelling and marketing ahead of 2027 to maintain market access.
Source: Gulf News
